Chaired by Prof. Joaquim M. S. Cabral
Instituto Superior Técnico, University of Lisbon, Portugal
The Stem Cell Community Day connects researchers from all over the world to discuss recent advances in the stem cells field, with a special focus on controlled cultivation in bioreactors.
Stem cell-based technologies lay the basis for pioneering approaches in regenerative medicine, drug screening, and toxicology testing. Their commercial use requires reliable methods for the large-scale production of stem cells in consistent quality.
At our 1st Stem Cell Community Day we brought together experts from industry and academia, to discuss recent achievements, challenges, and chances in stem cell bioprocessing for research and commercial manufacturing.
Caroline Halloin, MH Hannover, Germany:
CHEMICALLY DEFINED CARDIOMYOGENIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS IN BIOREACTORS
Leopold König, TissUse GmbH, Berlin, Germany:
SCALABLE PRODUCTION OF HUMAN PLURIPOTENT STEM CELL DERIVED NEUROSPHERES IN A SUSPENSION BIOREACTOR SYSTEM
Lucas-Sebastian Spitzhorn, Heinrich Heine University Hospital Dusseldorf, Germany:
HUMAN FETAL FORESKIN iPSC-DERIVED iMSCs SUPPORT REGENERATION IN A GOETTINGEN MINI-PIG BONE DEFECT MODEL
By Stacey Willard, PhD